Works matching IS 01435221 AND DT 2019 AND VI 133 AND IP 4

Results: 4
    1
    2
    3

    MiR-33a is a therapeutic target in SPG4-related hereditary spastic paraplegia human neurons.

    Published in:
    Clinical Science, 2019, v. 133, n. 4, p. 583, doi. 10.1042/CS20180980
    By:
    • Fumiko Nakazeki;
    • Itaru Tsuge;
    • Takahiro Horie;
    • Keiko Imamura;
    • Kayoko Tsukita;
    • Akitsu Hotta;
    • Osamu Baba;
    • Yasuhide Kuwabara;
    • Tomohiro Nishino;
    • Tetsushi Nakao;
    • Masataka Nishiga;
    • Hitoo Nishi;
    • Yasuhiro Nakashima;
    • Yuya Ide;
    • Satoshi Koyama;
    • Masahiro Kimura;
    • Shuhei Tsuji;
    • Motoko Naitoh;
    • Shigehiko Suzuki;
    • Yuishin Izumi
    Publication type:
    Article
    4